SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is experiencing a mix of speculative optimism regarding a potential price breakout and skepticism from traders who view it as a stagnant "shitcoin." Conversations are heavily focused on technical indicators, price level watchdogs, and comparisons to other trending meme coins while the community debates whether recent price action is a legitimate rally or a "pump and dump" scheme.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending amid a surge in price and heavy speculative activity, with many traders discussing its potential as a "privacy-focused" alternative to Bitcoin. While some investors are bullish on supply scarcity and institutional interest, others view the rapid ascent as an overextended rally driven by short squeezes.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

GlobalFoundries is trending as traders speculate on the company's long-term position in the AI infrastructure and semiconductor foundry space, driven by its recent patent litigation against Tower Semiconductor and its role in domestic chip manufacturing. While sentiment is divided between optimism regarding potential partnerships and institutional growth and bearishness stemming from recent price declines, discussion focuses on the stock's valuation as a key U.S. foundry.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is trending as analysts and investors highlight its domestic manufacturing advantage and potential tailwinds from impending Section 232 tariff decisions. The community remains focused on the company's strong backlog, role in powering AI data centers, and the perceived undervaluation of its growth profile relative to its earnings.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is trending as traders closely monitor Middle East geopolitical tensions and their impact on crude oil prices, with ongoing debate over potential ceasefire negotiations versus the risk of sustained supply disruptions. Market participants remain divided, weighing the company's strong cash flow and institutional interest against the volatility caused by conflicting reports on a possible peace deal.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is trending as traders speculate on a potential price rally driven by a perceived scarcity of supply and a desire for it to close the valuation gap with Zcash, another prominent privacy-focused project. While bullish investors point to these supply dynamics and recent privacy coin sentiment as catalysts for a "breakout," others maintain a more cautious or bearish outlook, citing historical resistance levels and market-wide volatility.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging after reporting strong quarterly results characterized by a double beat on revenue and earnings, alongside an upward revision to its full-year outlook and bullish guidance for accelerating growth in 2027. Community members are largely optimistic about the company's role in the AI infrastructure and data center hardware space, though some traders remain wary of potential price volatility and broader market headwinds affecting semiconductor and tech-related stocks.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

Attention is centered on the reported Google Cloud validation of Subsquid’s distributed database technology, which traders view as major infrastructure validation. While many are bullish on the potential for enterprise-scale adoption, skeptics argue that the announcement specifically highlights parent company Rezolve AI and express uncertainty about the token’s long-term utility.

Ethena

Ethena is trending as the community anticipates the activation of the ENA fee-switch and buyback mechanism once USDe supply hits specific growth milestones. Traders are divided between bullish sentiment regarding Ethena's institutional infrastructure and treasury growth, and skepticism focused on token dilution and the wait time for actual buybacks to commence.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trading in a volatile range as investors monitor the company's progress toward commercializing its small modular reactor (SMR) technology. While some traders express frustration over the lack of finalized contracts and recent revenue misses, others maintain a bullish outlook based on the potential for long-term nuclear power demand from data centers and the company's NRC design certification.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 results 2026: BHEL to Paytm among firms to declare Q4 earnings next week

… Fincorp 11 Ajanta Pharma 12 Emcure Pharmaceuticals 13 Aadhar Housing … Kriti Nutrients 46 Jenburkt Pharma 47 Kriti Industries (India) … Coast Hotels 61 Sandu Pharmaceuticals 62 Premier Energy and … STL Networks 39 Shukra Pharmaceuticals 40 Alldigi Tech 41 …

USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facility

Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra from April 13–21, 2026. The company stated it will respond within the stipulated timeframe, while noting that Form-483 is issued when inspectors observe potential regulatory violations.

Ajanta Pharma, Sun Pharma poised to tap GLP-1 opportunity amid market shift: Siddhartha Khemka

India's metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging among millions needing obesity management. Broader specialist adoption and a growing prescriber base are fueling this expansion, promising substantial market growth.

India’s Cheap Ozempic Moment Is Here: Ozempic Prices Set to Drop to ₹3,000 as Semaglutide Goes Off-Patent in India

… in the highly successful weight-loss drugs called “Ozempic” and “Wegovy” developed … such as Mankind Pharma Ltd., Ajanta Pharma Ltd., Sun Pharmaceutical Industries Ltd. and … nearly 20% of all generic drugs available globally. The most significant impact …

Raja Venkatraman, MarketSmith India recommends five stocks for 16 March

On March 13, Indian stock indices Sensex and Nifty 50 faced continued selling pressure due to rising crude oil prices and global economic concerns. GIFT Nifty today suggests a mildly positive start, with several stocks recommended for buying, including Ajanta Pharma and Power Grid Corporation.

Everstone to sell stake in Restaurant Brands Asia – report

The family office of the founders of Ajanta Pharma in India may inject up to Rs8bn ($88m) into RBA.

Everstone to sell entire stake in India's Burger King operator Restaurant Brands Asia, sources say

Private equity firm Everstone is set to exit Restaurant Brands Asia, the franchisee for Burger King in India and Indonesia. The firm will sell its entire 11.26% stake. The Ajanta Pharma family office is poised to become the new strategic investor. This move could see the family office injecting significant funds and potentially acquiring a majority stake in the company.

India’s Ajanta Pharma eyes Irish manufacturing base

Indian speciality pharmaceutical firm Ajanta Pharma is understood to be eyeing a manufacturing operation in Ireland.

Biocon to supply semaglutide to Ajanta for marketing in 26 countries

Indian drugmaker Biocon has announced the signing of an out-licensing agreement with Ajanta Pharma to market its vertically integrated drug product, semaglutide, used to improve glycemic control in adults with type-2 diabetes.

Indian equity benchmarks end flat in thin year-end trade; IT losses weigh

India’s equity benchmarks closed little changed on Wednesday in a subdued session marked by thin year-end volumes, with losses in information technology stocks weighing on sentiment. The Nifty 50 fell 0.13% to 26,142.1, while the BSE Sensex shed 0.14% to 85,408.7. Fifteen of the 16 major sectors declined. Small-caps rose 0.3%, while mid-caps fell 0.6%. Analysts said thin year-end trading kept volatility in check, with global volumes typically light ahead of the Christmas and New Year holidays. Indian markets will be closed on Thursday for Christmas. Investors are awaiting further cues, including a potential India-U.S. trade deal and October-December earnings, for a directional trade in the market. Motilal Oswal Financial Services said the earnings revision trends in the past four months have beaten its expectations. “The backdrop for earnings has improved vs last year, engineered by a series of stimulative fiscal and monetary measures,” the brokerage firm said. IT stocks fell 0.5% on the day after U.S.

Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The firm offers branded generics that serve a range of therapeutic segments such as antibiotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory, and general health. It operates through the following geographical segments: India, Africa, Asia, and USA. The company was founded by Purushottam Bhagwand Agrawal in 1973 and is headquartered in Mumbai, India.

Current Price	3,460.10
Prev Close	3,525.00
Open	3,503.50
Dividend Yield	1.00%
50-Day Moving Average	3,480.10
Beta	N/A
Avg. Volume	80,478.10
PE Ratio	38.14

52-Week High	3,796.00
52-Week Low	2,329.90
Market Capitalization	432.91B
EPS (Annual)	84.53
Price to Book	9.56
Revenue Per Employee	4.11M

Feed

News

Sentiment

Fundamentals

Info

AJANTPHARM.NSE Fundamentals